CS
STML

Candriam SCA’s Stemline Therapeutics, Inc. STML Stock Holding History

Candriam SCA’s Portfolio STML Stock Details STML Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
2020
Q1 		$1.55M Buy
2019
Q4 		$1.59M Buy
2019
Q3 		$1.19M Buy
2019
Q2 		$1.22M Buy
2017
Q1 		– Sell
2016
Q4 		$2.61M Sell
2016
Q3 		$2.78M Buy